- People
- Offices
- Capabilities
back- Capabilities
- Corporate, Finance and Investments
- back
- Corporate, Finance and Investments
- Overview
- Activist Defense
- Banking and Institutional Finance
- Capital Markets
- Construction and Procurement
- Corporate Governance
- Emerging Companies and Venture Capital
- Employee Benefits and Executive Compensation
- Energy and Infrastructure Projects
- Financial Restructuring
- Global Human Capital and Compliance
- Investment Funds and Asset Management
- Mergers and Acquisitions (M&A)
- Middle East and Islamic Finance and Investment
- Private Credit & Special Situations
- Private Equity
- Public Companies
- Real Estate
- Structured Finance and Securitization
- Tax
- Technology Transactions
- Government Matters
- back
- Government Matters
- Overview
- Antitrust
- Data, Privacy and Security
- Environmental, Health and Safety
- FDA and Life Sciences
- Government Advocacy and Public Policy
- Government Contracts
- Healthcare
- International Trade
- National Security and Corporate Espionage
- Securities Enforcement and Regulation
- Special Matters and Government Investigations
- Trial and Global Disputes
- back
- Trial and Global Disputes
- Overview
- Antitrust
- Appellate, Constitutional and Administrative Law
- Bankruptcy and Insolvency Litigation
- Class Action Defense
- Commercial Litigation
- Construction and Engineering Disputes
- Corporate and Securities Litigation
- E-Discovery
- Intellectual Property
- International Arbitration and Litigation
- Labor and Employment
- Product Liability
- Professional Liability
- Toxic & Environmental Torts
- Industries / Issues
- back
- Industries / Issues
- Automotive, Transportation and Mobility
- Energy
- Financial Services
- Food and Beverage
- Higher Education
- Life Sciences and Healthcare
- Technology
- #MeToo
- Buy American
- COVID-19 Vaccine Rollout
- Crisis Management
- Environmental Agenda
- Environmental, Social and Governance (ESG)
- Focus on Women's Health
- Russia/Ukraine
- Special Purpose Acquisition Companies (SPACs)
- Careers
- News & Insights
- About
- Languages
Events 176 results
Conference
April 26, 2023
FDA’s New Laws and Regulations Summit
Webinar
April 20, 2023
Revision of the EU Pharmaceutical Legislation - What To Expect
Speaking Engagement
March 15, 2023
Dale Giali to Speak at Class Action Law Forum
Webinar
March 13, 2023
Key Food and Beverage Issues: Challenges and Opportunities in 2023
Conference
March 8, 2023
California Life Sciences Summit
Speaking Engagement
February 23, 2023
Nikki Reeves, Heather Banuelos, Gillian Russell to Speak at DIA Global’s Advertising and Promotion Regulatory Affairs Conference
Webinar
February 23, 2023
MDLs: Judges, Defendants and Plaintiffs Too – Who Is Buzzing About What?
Speaking Engagement
February 23, 2023
Gillian Russell to Speak at DIA’s Advertising and Promotion Regulatory Affairs Conference
Webinar
January 24, 2023
Year in Review for Drug and Device Advertising and Promotion: Lessons Learned From 2022 FDA Enforcement Letters and Other Key Developments
Webinar
January 19, 2023
A New Year, A New Day - What’s Next for Healthcare Policy and Oversight in the New Congress
Speaking Engagement
December 16, 2022
Ulf Grundmann, Elisabeth Kohoutek to Speak at Hebrew University of Jerusalem’s BioMED MBA Program
Speaking Engagement
December 8, 2022
Eva Temkin to Speak at PLI’s Hot Topics in Health Care Law Conference